72-year-old De Niro, who is a father of an autistic child and co-founder of the festival, at first defended the decision to premiere "Vaxxed: from Cover-Up to Catastrophe", despite outcry from doctors and researchers.
Repeated studies involving more than a million children have found there is no evidence to link childhood vaccines to autism. But a small movement of activists persists in the belief that vaccinations might somehow harm children, reported Guardian.
"My intent in screening this film was to provide an opportunity for conversation around an issue that is deeply personal to me and my family," he said.
"But after reviewing it over the past few days with the Tribeca film festival team and others from the scientific community, we do not believe it contributes to or furthers the discussion I had hoped for.
"The Festival doesn't seek to avoid or shy away from controversy. However, we have concerns with certain things in this film that we feel prevent us from presenting it in the Festival program. We have decided to remove it from our schedule."
The paper was quickly found to contain numerous flaws and was deemed by the British Medical Journal "an elaborate fraud".
The Lancet, which originally published the study, retracted it in 2010, the same year that Wakefield lost was stripped of his licence to practise medicine in the UK.
Wakefield appears in the trailer for his film, and claims that the Centers for Disease Control and Prevention have hidden evidence that would support his discredited claims. The trailer also asks "are our children safe" over the image of smoke swirling out of a syringe.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
